N-Methyl-d-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat

Background Inflammatory bowel diseases are accompanied by severe motility disorders. The aim of our study was to investigate whether the blockade of peripheral N-methyl-D-aspartate (NMDA)-sensitive glutamate receptors (NMDA-Rs) alters motility changes in chemically induced acute colitis and how this...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Varga Gabriella
Érces Dániel
Fazekas Barbara
Fülöp M.
Kovács Tamás
Kaszaki József
Fülöp Ferenc
Vécsei László
Boros Mihály
Dokumentumtípus: Cikk
Megjelent: Wiley-Blackwell Publishing Ltd. 2010
Sorozat:NEUROGASTROENTEROLOGY AND MOTILITY 22 No. 2
doi:10.1111/j.1365-2982.2009.01390.x

mtmt:1298673
Online Access:http://publicatio.bibl.u-szeged.hu/9936
LEADER 02904nab a2200301 i 4500
001 publ9936
005 20200128090746.0
008 161116s2010 hu o 0|| zxx d
022 |a 1350-1925 
024 7 |a 10.1111/j.1365-2982.2009.01390.x  |2 doi 
024 7 |a 1298673  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Varga Gabriella 
245 1 0 |a N-Methyl-d-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat  |h [elektronikus dokumentum] /  |c  Varga Gabriella 
260 |a Wiley-Blackwell Publishing Ltd.  |c 2010 
300 |a 217-225+e68 
490 0 |a NEUROGASTROENTEROLOGY AND MOTILITY  |v 22 No. 2 
520 3 |a Background Inflammatory bowel diseases are accompanied by severe motility disorders. The aim of our study was to investigate whether the blockade of peripheral N-methyl-D-aspartate (NMDA)-sensitive glutamate receptors (NMDA-Rs) alters motility changes in chemically induced acute colitis and how this modulation is accomplished. Methods The inflammatory and motility changes in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis were studied in anaesthetized Wistar rats following treatment with the natural NMDA-R antagonist kynurenic acid (KynA) or SZR-72, a blood-brain barrier-permeable synthetic KynA analogue. The macrohaemodynamics, serosal microcirculation (visualized by intravital videomicroscopy), plasma levels of tumour necrosis factor alpha (TNF-alpha), inflammatory enzyme activities (xanthine oxidoreductase (XOR), myeloperoxidase (MPO) and nitric oxide synthase (NOS)), and colonic motility (with a strain-gauge technique) were evaluated 17 h after colitis induction and compared with the control conditions. Key Results The TNBS enema induced a systemic hyperdynamic circulatory reaction, increased the serosal capillary blood flow, significantly elevated the mucosal XOR, MPO and NOS activities and augmented the colonic motility relative to the controls. The NMDA-R antagonist treatment with KynA or SZR-72 significantly reduced the XOR, NOS and MPO activities, decreased the motility and increased the tone of the colon. Conclusions & Inferences These data demonstrate a potential modulatory mechanism of NMDA-R in altered colonic motility in TNBS colitis. Inhibition of the enteric NMDA-Rs may provide a therapeutic option via which to influence intestinal hypermotility, microcirculatory changes and inflammatory activation simultaneously. 
700 0 1 |a Érces Dániel  |e aut 
700 0 1 |a Fazekas Barbara  |e aut 
700 0 1 |a Fülöp M.  |e aut 
700 0 1 |a Kovács Tamás  |e aut 
700 0 1 |a Kaszaki József  |e aut 
700 0 1 |a Fülöp Ferenc  |e aut 
700 0 1 |a Vécsei László  |e aut 
700 0 1 |a Boros Mihály  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/9936/1/Varga_et_al_2010_Neurogastroenterology__Motility_u.pdf  |z Dokumentum-elérés